Header Logo

Francesca

Address
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Shaw ES, Stoker NG, Potter JL, Claassen H, Leslie A, Tweed CD, Chiang CY, Conradie F, Esmail H, Lange C, Pinto L, Rucsineanu O, Sloan DJ, Theron G, Tisile P, Voo TC, Warren RM, Lebina L, Lipman M. Bedaquiline: what might the future hold? Lancet Microbe. 2024 Jul 26; 100909. PMID: 39074472.
      Citations:    Fields:    
    2. Metcalfe JZ, Economou T, Naufal F, Kucukosmanoglu M, Kleiman R, Phillips PPJ, Conradie F. Validation of a Handheld 6-Lead Device for QT Interval Monitoring in Resource-Limited Settings. JAMA Netw Open. 2024 Jun 03; 7(6):e2415576. PMID: 38848063; PMCID: PMC11161846.
      Citations:    Fields:    Translation:Humans
    3. Lienhardt C, Dooley KE, Nahid P, Wells C, Ryckman TS, Kendall EA, Davies G, Brigden G, Churchyard G, Cirillo DM, Di Meco E, Gopinath R, Mitnick C, Scott C, Amanullah F, Bansbach C, Boeree M, Campbell M, Conradie F, Crook A, Daley CL, Dheda K, Diacon A, Gebhard A, Hanna D, Heinrich N, Hesseling A, Holtzman D, Jachym M, Kim P, Lange C, McKenna L, Meintjes G, Ndjeka N, Nhung NV, Nyang'wa BT, Paton NI, Rao R, Rich M, Savic R, Schoeman I, Makokotlela BS, Spigelman M, Sun E, Svensson E, Tisile P, Varaine F, Vernon A, Diul MY, Kasaeva T, Zignol M, Gegia M, Mirzayev F, Schumacher SG. Target regimen profiles for tuberculosis treatment. Bull World Health Organ. 2024 Aug 01; 102(8):600-607. PMID: 39070602; PMCID: PMC11276158.
      Citations: 3     Fields:    Translation:Humans
    4. Cevik M, Thompson LC, Upton C, Rolla VC, Malahleha M, Mmbaga B, Ngubane N, Abu Bakar Z, Rassool M, Variava E, Dawson R, Staples S, Lalloo U, Louw C, Conradie F, Eristavi M, Samoilova A, Skornyakov SN, Ntinginya NE, Haraka F, Praygod G, Mayanja-Kizza H, Caoili J, Balanag V, Dalcolmo MP, McHugh T, Hunt R, Solanki P, Bateson A, Crook AM, Fabiane S, Timm J, Sun E, Spigelman M, Sloan DJ, Gillespie SH, SimpliciTB Consortium. Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial. Lancet Infect Dis. 2024 Sep; 24(9):1003-1014. PMID: 38768617.
      Citations:    Fields:    Translation:HumansCellsCTClinical Trials
    5. Mkhize B, Court R, Castel S, Joubert A, van der Merwe M, Maartens G, Conradie F, Wiesner L. Validation and application of an online extraction and liquid chromatography tandem mass spectrometry assay for the analysis of delamanid and its DM-6705 metabolite in human breast milk. J Pharm Biomed Anal. 2024 Aug 15; 246:116225. PMID: 38761519.
      Citations:    Fields:    Translation:Humans
    6. Horak J, Venter WDF, Wattrus C, Papavarnavas N, Howell P, Sorour G, Wallis C, Gill K, Conradie F, Bekker LG. Southern African HIV Clinicians Society 2023 Guideline for post-exposure prophylaxis: Updated recommendations. South Afr J HIV Med. 2023; 24(1):1522. PMID: 37795431; PMCID: PMC10546897.
      Citations: 1     
    7. Dom?nguez J, Boeree MJ, Cambau E, Chesov D, Conradie F, Cox V, Dheda K, Dudnyk A, Farhat MR, Gagneux S, Grobusch MP, Gr?schel MI, Guglielmetti L, Kontsevaya I, Lange B, van Leth F, Lienhardt C, Mandalakas AM, Maurer FP, Merker M, Miotto P, Molina-Moya B, Morel F, Niemann S, Veziris N, Whitelaw A, Horsburgh CR, Lange C, TBnet and RESIST-TB networks. Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a 2023 TBnet/RESIST-TB consensus statement. Lancet Infect Dis. 2023 04; 23(4):e122-e137. PMID: 36868253.
      Citations: 14     Fields:    Translation:HumansCells
    8. Jassat W, Mudara C, Vika C, Welch R, Arendse T, Dryden M, Blumberg L, Mayet N, Tempia S, Parker A, Nel J, Perumal R, Groome MJ, Conradie F, Ndjeka N, Sigfrid L, Merson L, Cohen C. A cohort study of post-COVID-19 condition across the Beta, Delta, and Omicron waves in South Africa: 6-month follow-up of hospitalized and nonhospitalized participants. Int J Infect Dis. 2023 Mar; 128:102-111. PMID: 36587841; PMCID: PMC9800016.
      Citations: 16     Fields:    Translation:Humans
    9. Goodall RL, Meredith SK, Nunn AJ, Bayissa A, Bhatnagar AK, Bronson G, Chiang CY, Conradie F, Gurumurthy M, Kirenga B, Kiria N, Meressa D, Moodliar R, Narendran G, Ngubane N, Rassool M, Sanders K, Solanki R, Squire SB, Torrea G, Tsogt B, Tudor E, Van Deun A, Rusen ID, STREAM study collaborators. Evaluation of two short standardised regimens for the treatment of rifampicin-resistant tuberculosis (STREAM stage 2): an open-label, multicentre, randomised, non-inferiority trial. Lancet. 2022 11 26; 400(10366):1858-1868. PMID: 36368336; PMCID: PMC7614824.
      Citations: 28     Fields:    Translation:Humans
    10. Dryden M, Mudara C, Vika C, Blumberg L, Mayet N, Cohen C, Tempia S, Parker A, Nel J, Perumal R, Groome MJ, Conradie F, Ndjeka N, Sigfrid L, Merson L, Jassat W. Post-COVID-19 condition 3 months after hospitalisation with SARS-CoV-2 in South Africa: a prospective cohort study. Lancet Glob Health. 2022 09; 10(9):e1247-e1256. PMID: 35961348; PMCID: PMC9363040.
      Citations: 25     Fields:    Translation:HumansCells
    11. Conradie F, Bagdasaryan TR, Borisov S, Howell P, Mikiashvili L, Ngubane N, Samoilova A, Skornykova S, Tudor E, Variava E, Yablonskiy P, Everitt D, Wills GH, Sun E, Olugbosi M, Egizi E, Li M, Holsta A, Timm J, Bateson A, Crook AM, Fabiane SM, Hunt R, McHugh TD, Tweed CD, Foraida S, Mendel CM, Spigelman M, ZeNix Trial Team. Bedaquiline-Pretomanid-Linezolid Regimens for Drug-Resistant Tuberculosis. N Engl J Med. 2022 09 01; 387(9):810-823. PMID: 36053506; PMCID: PMC9490302.
      Citations: 102     Fields:    Translation:Humans
    12. Imperial MZ, Nedelman JR, Conradie F, Savic RM. Proposed Linezolid Dosing Strategies to Minimize Adverse Events for Treatment of Extensively Drug-Resistant Tuberculosis. Clin Infect Dis. 2022 May 30; 74(10):1736-1747. PMID: 34604901.
      Citations: 18     Fields:    Translation:HumansCTClinical Trials
    13. Ndjeka N, Campbell JR, Meintjes G, Maartens G, Schaaf HS, Hughes J, Padanilam X, Reuter A, Romero R, Ismail F, Enwerem M, Ferreira H, Conradie F, Naidoo K, Menzies D. Treatment outcomes 24 months after initiating short, all-oral bedaquiline-containing or injectable-containing rifampicin-resistant tuberculosis treatment regimens in South Africa: a retrospective cohort study. Lancet Infect Dis. 2022 May 02. PMID: 35512718.
      Citations: 19     Fields:    Translation:Humans
    14. Gomez GB, Siapka M, Conradie F, Ndjeka N, Garfin AMC, Lomtadze N, Avaliani Z, Kiria N, Malhotra S, Cook-Scalise S, Juneja S, Everitt D, Spigelman M, Vassall A. Cost-effectiveness of bedaquiline, pretomanid and linezolid for treatment of extensively drug-resistant tuberculosis in South Africa, Georgia and the Philippines. BMJ Open. 2021 12 03; 11(12):e051521. PMID: 34862287; PMCID: PMC8647530.
      Citations: 10     Fields:    Translation:Humans
    15. Ismail NA, Omar SV, Moultrie H, Bhyat Z, Conradie F, Enwerem M, Ferreira H, Hughes J, Joseph L, Kock Y, Letsaolo V, Maartens G, Meintjes G, Ngcamu D, Okozi N, Padanilam X, Reuter A, Romero R, Schaaf S, Te Riele J, Variava E, van der Meulen M, Ismail F, Ndjeka N. Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: a cross-sectional and longitudinal study. Lancet Infect Dis. 2022 04; 22(4):496-506. PMID: 34780706.
      Citations: 32     Fields:    Translation:HumansCells
    16. Penn-Nicholson A, Georghiou SB, Ciobanu N, Kazi M, Bhalla M, David A, Conradie F, Ruhwald M, Crudu V, Rodrigues C, Myneedu VP, Scott L, Denkinger CM, Schumacher SG, Xpert XDR Trial Consortium. Detection of isoniazid, fluoroquinolone, ethionamide, amikacin, kanamycin, and capreomycin resistance by the Xpert MTB/XDR assay: a cross-sectional multicentre diagnostic accuracy study. Lancet Infect Dis. 2022 02; 22(2):242-249. PMID: 34627496.
      Citations: 38     Fields:    Translation:HumansCells
    17. Dooley KE, Rosenkranz SL, Conradie F, Moran L, Hafner R, von Groote-Bidlingmaier F, Lama JR, Shenje J, De Los Rios J, Comins K, Morganroth J, Diacon AH, Cramer YS, Donahue K, Maartens G, AIDS Clinical Trials Group (ACTG) A5343 DELIBERATE Study Team. QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial. Lancet Infect Dis. 2021 07; 21(7):975-983. PMID: 33587897; PMCID: PMC8312310.
      Citations: 36     Fields:    Translation:HumansCTClinical Trials
    18. Nel JS, Conradie F, Botha J, Etheredge H, Fabian J, Levin L, Mazanderani AH, Moorhouse M, Muller E, Tiemessen C, Thomson D, Turner J. Southern African HIV Clinicians Society guidelines for solid organ transplantation in human immunodeficiency virus: An evidence-based framework for human immunodeficiency virus-positive donors and recipients. South Afr J HIV Med. 2020; 21(1):1133. PMID: 33240537; PMCID: PMC7670031.
      Citations: 2     
    19. Ndjeka N, Conradie F, Meintjes G, Reuter A, Hughes J, Padanilam X, Ismail N, Kock Y, Master I, Romero R, Te Riele J, Enwerem M, Ferreira H, Maartens G. Responding to SARS-CoV-2 in South Africa: what can we learn from drug-resistant tuberculosis? Eur Respir J. 2020 07; 56(1). PMID: 32471936; PMCID: PMC7257618.
      Citations: 5     Fields:    Translation:HumansPHPublic Health
    20. Conradie F, Everitt D, Crook AM. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. Reply. N Engl J Med. 2020 06 11; 382(24):2377. PMID: 32521143.
      Citations: 6     Fields:    Translation:Humans
    21. Abidi S, Achar J, Assao Neino MM, Bang D, Benedetti A, Brode S, Campbell JR, Casas EC, Conradie F, Dravniece G, du Cros P, Falzon D, Jaramillo E, Kuaban C, Lan Z, Lange C, Li PZ, Makhmudova M, Maug AKJ, Menzies D, Migliori GB, Miller A, Myrzaliev B, Ndjeka N, Noeske J, Parpieva N, Piubello A, Schwoebel V, Sikhondze W, Singla R, Souleymane MB, Trébucq A, Van Deun A, Viney K, Weyer K, Zhang BJ, Ahmad Khan F. Standardised shorter regimens versus individualised longer regimens for rifampin- or multidrug-resistant tuberculosis. Eur Respir J. 2020 03; 55(3). PMID: 31862767.
      Citations: 35     Fields:    Translation:HumansCells
    22. Conradie F, Diacon AH, Ngubane N, Howell P, Everitt D, Crook AM, Mendel CM, Egizi E, Moreira J, Timm J, McHugh TD, Wills GH, Bateson A, Hunt R, Van Niekerk C, Li M, Olugbosi M, Spigelman M, Nix-TB Trial Team. Treatment of Highly Drug-Resistant Pulmonary Tuberculosis. N Engl J Med. 2020 03 05; 382(10):893-902. PMID: 32130813; PMCID: PMC6955640.
      Citations: 322     Fields:    Translation:HumansCellsCTClinical Trials
    23. Suryavanshi N, Murrill M, Gupta A, Hughes M, Hesseling A, Kim S, Naini L, Jones L, Smith B, Gupte N, Dawson R, Mave V, Meshram S, Mendoza-Ticona A, Sanchez J, Kumarasamy N, Comins K, Conradie F, Shenje J, Nerette Fontain S, Garcia-Prats A, Asmelash A, Nedsuwan S, Mohapi L, Lalloo U, Cristina Garcia Ferreira A, Okeyo E, Swindells S, Churchyard G, Shah NS. Willingness to Take Multidrug-resistant Tuberculosis (MDR-TB) Preventive Therapy Among Adult and Adolescent Household Contacts of MDR-TB Index Cases: An International Multisite Cross-sectional Study. Clin Infect Dis. 2020 01 16; 70(3):436-445. PMID: 30919881; PMCID: PMC7188234.
      Citations: 5     Fields:    Translation:Humans
    24. Gupta A, Swindells S, Kim S, Hughes MD, Naini L, Wu X, Dawson R, Mave V, Sanchez J, Mendoza A, Gonzales P, Kumarasamy N, Comins K, Conradie F, Shenje J, Fontain SN, Garcia-Prats A, Asmelash A, Nedsuwan S, Mohapi L, Lalloo UG, Ferreira ACG, Mugah C, Harrington M, Jones L, Cox SR, Smith B, Shah NS, Hesseling AC, Churchyard G. Feasibility of Identifying Household Contacts of Rifampin-and Multidrug-resistant Tuberculosis Cases at High Risk of Progression to Tuberculosis Disease. Clin Infect Dis. 2020 01 16; 70(3):425-435. PMID: 30942853; PMCID: PMC7188224.
      Citations: 14     Fields:    Translation:Humans
    25. Tweed CD, Dawson R, Burger DA, Conradie A, Crook AM, Mendel CM, Conradie F, Diacon AH, Ntinginya NE, Everitt DE, Haraka F, Li M, van Niekerk CH, Okwera A, Rassool MS, Reither K, Sebe MA, Staples S, Variava E, Spigelman M. Bedaquiline, moxifloxacin, pretomanid, and pyrazinamide during the first 8 weeks of treatment of patients with drug-susceptible or drug-resistant pulmonary tuberculosis: a multicentre, open-label, partially randomised, phase 2b trial. Lancet Respir Med. 2019 12; 7(12):1048-1058. PMID: 31732485; PMCID: PMC7641992.
      Citations: 50     Fields:    Translation:HumansCTClinical Trials
    26. Botha J, Fabian J, Etheredge H, Conradie F, Tiemessen CT. HIV and Solid Organ Transplantation: Where Are we Now. Curr HIV/AIDS Rep. 2019 10; 16(5):404-413. PMID: 31482298; PMCID: PMC6813753.
      Citations: 11     Fields:    Translation:Humans
    27. Etheredge HR, Fabian J, Duncan M, Conradie F, Tiemessen C, Botha J. Needs must: living donor liver transplantation from an HIV-positive mother to her HIV-negative child in Johannesburg, South Africa. J Med Ethics. 2019 05; 45(5):287-290. PMID: 31085631; PMCID: PMC6582740.
      Citations: 3     Fields:    Translation:Humans
    28. Nunn AJ, Phillips PPJ, Meredith SK, Chiang CY, Conradie F, Dalai D, van Deun A, Dat PT, Lan N, Master I, Mebrahtu T, Meressa D, Moodliar R, Ngubane N, Sanders K, Squire SB, Torrea G, Tsogt B, Rusen ID, STREAM Study Collaborators. A Trial of a Shorter Regimen for Rifampin-Resistant Tuberculosis. N Engl J Med. 2019 03 28; 380(13):1201-1213. PMID: 30865791.
      Citations: 146     Fields:    Translation:HumansCTClinical Trials
    29. Moorhouse M, Maartens G, Venter WDF, Moosa MY, Steegen K, Jamaloodien K, Fox MP, Conradie F. Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes. J Acquir Immune Defic Syndr. 2019 01 01; 80(1):73-78. PMID: 30334876; PMCID: PMC6319697.
      Citations: 27     Fields:    Translation:Humans
    30. Ndjeka N, Schnippel K, Master I, Meintjes G, Maartens G, Romero R, Padanilam X, Enwerem M, Chotoo S, Singh N, Hughes J, Variava E, Ferreira H, Te Riele J, Ismail N, Mohr E, Bantubani N, Conradie F. High treatment success rate for multidrug-resistant and extensively drug-resistant tuberculosis using a bedaquiline-containing treatment regimen. Eur Respir J. 2018 12; 52(6). PMID: 30361246.
      Citations: 57     Fields:    Translation:Humans
    31. Ismail NA, McCarthy K, Conradie F, Stevens W, Ndjeka N. Multidrug-resistant tuberculosis outbreak in South Africa. Lancet Infect Dis. 2019 02; 19(2):134-135. PMID: 30528116.
      Citations:    Fields:    Translation:HumansPHPublic Health
    32. Ferrian S, Ross M, Conradie F, Vally Omar S, Ismail N, Little F, Kaplan G, Fallows D, Gray CM. Frequency of Circulating CD4+Ki67+HLA-DR- T Regulatory Cells Prior to Treatment for Multidrug Resistant Tuberculosis Can Differentiate the Severity of Disease and Predict Time to Culture Conversion. Front Immunol. 2018; 9:2438. PMID: 30410488; PMCID: PMC6209685.
      Citations: 5     Fields:    Translation:HumansCells
    33. Botha J, Conradie F, Etheredge H, Fabian J, Duncan M, Haeri Mazanderani A, Paximadis M, Maher H, Britz R, Loveland J, Ströbele B, Rambarran S, Mahomed A, Terblanche A, Beretta M, Brannigan L, Pienaar M, Archibald-Durham L, Lang A, Tiemessen CT. Living donor liver transplant from an HIV-positive mother to her HIV-negative child: opening up new therapeutic options. AIDS. 2018 10 23; 32(16):F13-F19. PMID: 30281558; PMCID: PMC6200383.
      Citations: 9     Fields:    Translation:HumansCells
    34. Moorhouse MA, Carmona S, Davies N, Dlamini S, van Vuuren C, Manzini T, Mathe M, Moosa Y, Nash J, Nel J, Pakade Y, Woods J, van Zyl G, Conradie F, Venter F, Meintjes G. Appropriate clinical use of darunavir 800 mg. South Afr J HIV Med. 2018; 19(1):918. PMID: 30473878; PMCID: PMC6244068.
      Citations:    
    35. Moorhouse MA, Carmona S, Davies N, Dlamini S, van Vuuren C, Manzini T, Mathe M, Moosa Y, Nash J, Nel J, Pakade Y, Woods J, van Zyl G, Conradie F, Venter F, Meintjes G. Southern African HIV Clinicians Society Guidance on the use of dolutegravir in first-line antiretroviral therapy. South Afr J HIV Med. 2018; 19(1):917. PMID: 30473877; PMCID: PMC6244149.
      Citations: 5     
    36. Schnippel K, Ndjeka N, Maartens G, Meintjes G, Master I, Ismail N, Hughes J, Ferreira H, Padanilam X, Romero R, Te Riele J, Conradie F. Effect of bedaquiline on mortality in South African patients with drug-resistant tuberculosis: a retrospective cohort study. Lancet Respir Med. 2018 09; 6(9):699-706. PMID: 30001994.
      Citations: 99     Fields:    Translation:Humans
    37. Schnippel K, Firnhaber C, Conradie F, Ndjeka N, Sinanovic E. Incremental Cost Effectiveness of Bedaquiline for the Treatment of Rifampicin-Resistant Tuberculosis in South Africa: Model-Based Analysis. Appl Health Econ Health Policy. 2018 Feb; 16(1):43-54. PMID: 28980217.
      Citations: 7     Fields:    Translation:Humans
    38. Schnippel K, Firnhaber C, Ndjeka N, Conradie F, Page-Shipp L, Berhanu R, Sinanovic E. Persistently high early mortality despite rapid diagnostics for drug-resistant tuberculosis cases in South Africa. Int J Tuberc Lung Dis. 2017 10 01; 21(10):1106-1111. PMID: 28911353.
      Citations: 8     Fields:    Translation:Humans
    39. Venter F, Majam M, Jankelowitz L, Adams S, Moorhouse M, Carmona S, Stevens W, Msimanga BR, Allen D, Balani P, Nevhutalu Z, Rhagnath N, Shroufi A, Devillé W, Kazangarare V, van der Wiel R, Templeman H, Puren A, Tucker T, van Cutsem G, Conradie F, Dong K, Chidarikire T, Gray A. South African HIV self-testing policy and guidance considerations. South Afr J HIV Med. 2017; 18(1):775. PMID: 29568643; PMCID: PMC5842980.
      Citations: 25     
    40. Meintjes G, Moorhouse MA, Carmona S, Davies N, Dlamini S, van Vuuren C, Manzini T, Mathe M, Moosa Y, Nash J, Nel J, Pakade Y, Woods J, Van Zyl G, Conradie F, Venter F. Adult antiretroviral therapy guidelines 2017. South Afr J HIV Med. 2017; 18(1):776. PMID: 29568644; PMCID: PMC5843236.
      Citations: 106     
    41. Ferrian S, Manca C, Lubbe S, Conradie F, Ismail N, Kaplan G, Gray CM, Fallows D. A combination of baseline plasma immune markers can predict therapeutic response in multidrug resistant tuberculosis. PLoS One. 2017; 12(5):e0176660. PMID: 28464011; PMCID: PMC5413057.
      Citations: 13     Fields:    Translation:Humans
    42. Padayatchi N, Naidu N, Friedland G, Naidoo K, Conradie F, Naidoo K, O'Donnell MR. Turning the tide against tuberculosis. Int J Infect Dis. 2017 Mar; 56:6-9. PMID: 28167256.
      Citations: 1     Fields:    Translation:Humans
    43. Brennan AT, Bor J, Davies MA, Conradie F, Maskew M, Long L, Sanne I, Fox MP. Tenofovir stock shortages have limited impact on clinic- and patient-level HIV treatment outcomes in public sector clinics in South Africa. Trop Med Int Health. 2017 02; 22(2):241-251. PMID: 27862762.
      Citations: 8     Fields:    Translation:Humans
    44. Venter WF, Kaiser B, Pillay Y, Conradie F, Gomez GB, Clayden P, Matsolo M, Amole C, Rutter L, Abdullah F, Abrams EJ, Casas CP, Barnhart M, Pillay A, Pozniak A, Hill A, Fairlie L, Boffito M, Moorhouse M, Chersich M, Serenata C, Quevedo J, Loots G. Cutting the cost of South African antiretroviral therapy using newer, safer drugs. S Afr Med J. 2016 Dec 21; 107(1):28-30. PMID: 28112085.
      Citations: 20     Fields:    Translation:Humans
    45. Godfrey C, Andersen J, Mngqibisa R, Scott LE, Conradie F. Tuberculosis control. Lancet. 2016 Mar 19; 387(10024):1157-8. PMID: 27025326.
      Citations:    Fields:    Translation:HumansPHPublic Health
    46. Schnippel K, Ndjeka N, Conradie F, Berhanu R, Claasen Z, Banoo S, Firnhaber C. A call to action: Addressing the reproductive health needs of women with drug-resistant tuberculosis. S Afr Med J. 2016 Mar 17; 106(4):30-1. PMID: 27032841.
      Citations: 6     Fields:    Translation:Humans
    47. Bekker LG, Rebe K, Venter F, Maartens G, Moorhouse M, Conradie F, Wallis C, Black V, Harley B, Eakles R. Southern African guidelines on the safe use of pre-exposure prophylaxis in persons at risk of acquiring HIV-1 infection. South Afr J HIV Med. 2016; 17(1):455. PMID: 29568613; PMCID: PMC5843155.
      Citations: 64     
    48. Moorhouse M, Conradie F, Venter F. What is the role of CD4 count in a large public health antiretroviral programme? South Afr J HIV Med. 2016; 17(1):446. PMID: 29568607; PMCID: PMC5843041.
      Citations: 9     
    49. Pandie M, Wiesner L, McIlleron H, Hughes J, Siwendu S, Conradie F, Variava E, Maartens G. Drug-drug interactions between bedaquiline and the antiretrovirals lopinavir/ritonavir and nevirapine in HIV-infected patients with drug-resistant TB. J Antimicrob Chemother. 2016 Apr; 71(4):1037-40. PMID: 26747099.
      Citations: 15     Fields:    Translation:Humans
    50. Meintjes G, Black J, Conradie F, Dlamini S, Maartens G, Manzini TC, Mathe M, Moorhouse M, Moosa Y, Nash J, Orrell C, Venter F, Wilson D. Southern African HIV Clinicians Society adult antiretroviral therapy guidelines: Update on when to initiate antiretroviral therapy. South Afr J HIV Med. 2015; 16(1):428. PMID: 29568598; PMCID: PMC5843256.
      Citations: 11     
    51. Pym AS, Diacon AH, Tang SJ, Conradie F, Danilovits M, Chuchottaworn C, Vasilyeva I, Andries K, Bakare N, De Marez T, Haxaire-Theeuwes M, Lounis N, Meyvisch P, Van Baelen B, van Heeswijk RP, Dannemann B, TMC207-C209 Study Group. Bedaquiline in the treatment of multidrug- and extensively drug-resistant tuberculosis. Eur Respir J. 2016 Feb; 47(2):564-74. PMID: 26647431.
      Citations: 115     Fields:    Translation:HumansCTClinical Trials
    52. Moorhouse M, Bekker LG, Black V, Conradie F, Harley B, Howell P, Maartens G, Papavarnavas T, Rebe K, Sorour G, Venter F, Wallis CL. Guideline on the management of occupational and non-occupational exposure to the human immunodeficiency virus and recommendations for post-exposure prophylaxis: 2015 Update. South Afr J HIV Med. 2015; 16(1):399. PMID: 29568597; PMCID: PMC5843151.
      Citations: 8     
    53. Riou C, Gray CM, Lugongolo M, Gwala T, Kiravu A, Deniso P, Stewart-Isherwood L, Omar SV, Grobusch MP, Coetzee G, Conradie F, Ismail N, Kaplan G, Fallows D. A subset of circulating blood mycobacteria-specific CD4 T cells can predict the time to Mycobacterium tuberculosis sputum culture conversion. PLoS One. 2014; 9(7):e102178. PMID: 25048802; PMCID: PMC4105550.
      Citations: 15     Fields:    Translation:HumansCells
    54. Dawany N, Showe LC, Kossenkov AV, Chang C, Ive P, Conradie F, Stevens W, Sanne I, Azzoni L, Montaner LJ. Identification of a 251 gene expression signature that can accurately detect M. tuberculosis in patients with and without HIV co-infection. PLoS One. 2014; 9(2):e89925. PMID: 24587128; PMCID: PMC3934945.
      Citations: 20     Fields:    Translation:HumansCells
    55. Conradie F, Mabiletsa T, Sefoka M, Mabaso S, Louw R, Evans D, Van Rie A. Prevalence and incidence of symmetrical symptomatic peripheral neuropathy in patients with multidrug-resistant TB. S Afr Med J. 2013 Oct 11; 104(1):24-6. PMID: 24388081.
      Citations: 9     Fields:    Translation:Humans
    56. Eley T, Huang SP, Conradie F, Zorrilla CD, Josipovic D, Botes M, Osiyemi O, Hardy H, Bertz R, McGrath D. Clinical and pharmacogenetic factors affecting neonatal bilirubinemia following atazanavir treatment of mothers during pregnancy. AIDS Res Hum Retroviruses. 2013 Oct; 29(10):1287-92. PMID: 23782005; PMCID: PMC3785800.
      Citations: 4     Fields:    Translation:HumansCTClinical Trials
    57. Hamers RL, Straatsma E, Kityo C, Wallis CL, Stevens WS, Sigaloff KC, Siwale M, Conradie F, Botes ME, Mandaliya K, Wellington M, Osibogun A, van Vugt M, Rinke de Wit TF, PharmAccess African Studies to Evaluate Resistance. Building capacity for the assessment of HIV drug resistance: experiences from the PharmAccess African Studies to Evaluate Resistance network. Clin Infect Dis. 2012 May; 54 Suppl 4:S261-5. PMID: 22544185.
      Citations: 6     Fields:    Translation:HumansPHPublic Health
    58. Venter F, Rees H, Pillay Y, Simelela N, Mbengashe TM, Geffen N, Conradie F, Shisana O, Rech D, Serenata C, Taljaard D, Gray G. The medical proof doesn't get much better than VMMC. S Afr Med J. 2012 Feb 23; 102(3 Pt 1):124-5; discussion 125-6. PMID: 22380896.
      Citations: 2     Fields:    Translation:Humans
    59. Wallis CL, Papathanasopolous MA, Fox M, Conradie F, Ive P, Orrell C, Zeinecker J, Sanne I, Wood R, McIntyre J, Stevens W, CIPRA-SA project 1 study team. Low rates of nucleoside reverse transcriptase inhibitor resistance in a well-monitored cohort in South Africa on antiretroviral therapy. Antivir Ther. 2012; 17(2):313-20. PMID: 22293461; PMCID: PMC3600633.
      Citations: 14     Fields:    Translation:HumansCells
    60. Conradie F, Foulkes AS, Ive P, Yin X, Roussos K, Glencross DK, Lawrie D, Stevens W, Montaner LJ, Sanne I, Azzoni L. Natural killer cell activation distinguishes Mycobacterium tuberculosis-mediated immune reconstitution syndrome from chronic HIV and HIV/MTB coinfection. J Acquir Immune Defic Syndr. 2011 Nov 01; 58(3):309-18. PMID: 21826013; PMCID: PMC3196770.
      Citations: 28     Fields:    Translation:HumansCells
    61. Hamers RL, Wallis CL, Kityo C, Siwale M, Mandaliya K, Conradie F, Botes ME, Wellington M, Osibogun A, Sigaloff KC, Nankya I, Schuurman R, Wit FW, Stevens WS, van Vugt M, de Wit TF, PharmAccess African Studies to Evaluate Resistance (PASER). HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. Lancet Infect Dis. 2011 Oct; 11(10):750-9. PMID: 21802367.
      Citations: 151     Fields:    Translation:HumansCellsPHPublic Health
    62. Ciaranello AL, Lockman S, Freedberg KA, Hughes M, Chu J, Currier J, Wood R, Holmes CB, Pillay S, Conradie F, McIntyre J, Losina E, Walensky RP, CEPAC-International and OCTANE Investigators. First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial. AIDS. 2011 Feb 20; 25(4):479-92. PMID: 21293199; PMCID: PMC3068908.
      Citations: 14     Fields:    Translation:HumansPHPublic Health
    63. Orrell C, Cohen K, Conradie F, Zeinecker J, Ive P, Sanne I, Wood R. Efavirenz and rifampicin in the South African context: is there a need to dose-increase efavirenz with concurrent rifampicin therapy? Antivir Ther. 2011; 16(4):527-34. PMID: 21685540; PMCID: PMC3145153.
      Citations: 11     Fields:    Translation:HumansCTClinical Trials
    64. Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PC, Ngorima N, Kantipong P, Osibogun A, Lee CK, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YM, Schuurman R, van Vugt M, Rinke de Wit TF, PharmAccess African PASER and TREAT Asia Studies to Evaluate Resistance. Cohort profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) monitoring studies to evaluate resistance--HIV drug resistance in sub-Saharan Africa and the Asia-Pacific. Int J Epidemiol. 2012 Feb; 41(1):43-54. PMID: 21071386; PMCID: PMC3304520.
      Citations: 36     Fields:    Translation:HumansCellsPHPublic Health
    65. Lockman S, Hughes MD, McIntyre J, Zheng Y, Chipato T, Conradie F, Sawe F, Asmelash A, Hosseinipour MC, Mohapi L, Stringer E, Mngqibisa R, Siika A, Atwine D, Hakim J, Shaffer D, Kanyama C, Wools-Kaloustian K, Salata RA, Hogg E, Alston-Smith B, Walawander A, Purcelle-Smith E, Eshleman S, Rooney J, Rahim S, Mellors JW, Schooley RT, Currier JS, OCTANE A5208 Study Team. Antiretroviral therapies in women after single-dose nevirapine exposure. N Engl J Med. 2010 Oct 14; 363(16):1499-509. PMID: 20942666; PMCID: PMC2994321.
      Citations: 74     Fields:    Translation:HumansCellsPHPublic Health
    66. Boulle A, Clayden P, Cohen K, Cohen T, Conradie F, Dong K, Geffen N, Grimwood A, Hurtado R, Kenyon C, Lawn S, Maartens G, Meintjes G, Mendelson M, Murray M, Rangaka M, Sanne I, Spencer D, Taljaard J, Variava E, Venter WD, Wilson D. Prolonged deferral of antiretroviral therapy in the SAPIT trial: did we need a clinical trial to tell us that this would increase mortality? S Afr Med J. 2010 Sep 07; 100(9):566, 568, 570-1. PMID: 20822639.
      Citations: 5     Fields:    Translation:Humans
    67. Fox MP, Sanne IM, Conradie F, Zeinecker J, Orrell C, Ive P, Rassool M, Dehlinger M, van der Horst C, McIntyre J, Wood R. Initiating patients on antiretroviral therapy at CD4 cell counts above 200 cells/microl is associated with improved treatment outcomes in South Africa. AIDS. 2010 Aug 24; 24(13):2041-50. PMID: 20613459; PMCID: PMC2914833.
      Citations: 23     Fields:    Translation:Humans
    68. Sanne I, Orrell C, Fox MP, Conradie F, Ive P, Zeinecker J, Cornell M, Heiberg C, Ingram C, Panchia R, Rassool M, Gonin R, Stevens W, Truter H, Dehlinger M, van der Horst C, McIntyre J, Wood R, CIPRA-SA Study Team. Nurse versus doctor management of HIV-infected patients receiving antiretroviral therapy (CIPRA-SA): a randomised non-inferiority trial. Lancet. 2010 Jul 03; 376(9734):33-40. PMID: 20557927; PMCID: PMC3145152.
      Citations: 112     Fields:    Translation:HumansCells
    69. Westreich DJ, Sanne I, Maskew M, Malope-Kgokong B, Conradie F, Majuba P, Funk MJ, Kaufman JS, Van Rie A, Macphail P. Tuberculosis treatment and risk of stavudine substitution in first-line antiretroviral therapy. Clin Infect Dis. 2009 Jun 01; 48(11):1617-23. PMID: 19385733; PMCID: PMC2787193.
      Citations: 20     Fields:    Translation:Humans
    70. van der Merwe K, Chersich MF, Technau K, Umurungi Y, Conradie F, Coovadia A. Integration of antiretroviral treatment within antenatal care in Gauteng Province, South Africa. J Acquir Immune Defic Syndr. 2006 Dec 15; 43(5):577-81. PMID: 17031321.
      Citations: 23     Fields:    Translation:HumansPHPublic Health
    71. Conradie F, Sanne I, Venter W, Eron J. Failure of lopinavir-ritonavir (Kaletra)-containing regimen in an antiretroviral-naive patient. AIDS. 2004 Apr 30; 18(7):1084-5. PMID: 15096819.
      Citations: 3     Fields:    Translation:Humans
    72. Reed RP, Conradie FM. The epidemiology and clinical features of paraffin (kerosene) poisoning in rural African children. Ann Trop Paediatr. 1997 Mar; 17(1):49-55. PMID: 9176578.
      Citations: 2     Fields:    Translation:Humans
    73. SMIT ZM, THERON JJ, CONRADIE FM. Studies in metabolism of zinc. Part I. Serum-zinc levels in outwardly healthy adults, white and Bantu. S Afr J Lab Clin Med. 1960 Mar; 6:29-36. PMID: 13854849.
      Citations:    Translation:Humans
    74. THERON JJ, MEYER BJ, CONRADIE FM. Serum; copper levels of the South African Bantu. S Afr J Lab Clin Med. 1958 Dec; 4(4):294-8. PMID: 13624814.
      Citations:    Translation:Humans
    CONRADIE's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (232)
    Explore
    _
    Co-Authors (29)
    Explore
    _
    Similar People (60)
    Explore
    _